LANXESS: EBITDA pre exceptionals for second quarter 2024 significantly above market expectation
Specialty chemicals company LANXESS expects to achieve a second quarter 2024 EBITDA pre exceptionals that considerably exceeds average market expectation and previous year's level.
The preliminary EBITDA pre exceptionals for the second quarter 2024, still subject to auditors’ review, is expected to amount to EUR 181 million which exceeds average market expectation of EUR 137 million (VARA consensus) by 32 percent and the prior year’s quarter by 69 percent which amounted to EUR 107 million EBITDA pre.
The second quarter result was driven by higher utilization rates following the severe and intended inventory reduction in 2023. Further support came from the successful implementation of LANXESS’ cost saving program. Compared to the second quarter of 2023, sales volumes increased in some customer industries, albeit offset by a persistent weak demand for agro chemicals and ongoing difficult market conditions in the construction industry.
LANXESS CEO Matthias Zachert: “We are benefiting from the fact that we have consistently adjusted our cost structures in recent months and have become more efficient: wherever demand picks up further, we will be in a far better position to benefit from it. Although we do not see any signs of a broad market recovery, we are confident, that we are well positioned as we have successfully strengthened our portfolio towards sustainability and market leadership over the past few years.”
LANXESS confirms the full-year EBITDA pre guidance of an expected growth of 10 to 20 percent versus previous year and now expects EBITDA pre for the third quarter 2024 to be close or up to the level of the second quarter.
LANXESS will release its full results for the second quarter of 2024 on August 9, 2024.
Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.
Information for editors:
All LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com. Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.
You can find further information concerning LANXESS chemistry at http://lanxess.com/en/Media/Stories.
